Does Rallies show 13F holders for ZBH?

Yes. Rallies tracks hedge fund and 13F ownership data for ZBH, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ZBH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ZBH. It does not provide personalized investment advice.

ZBH (Zimmer Biomet) Stock Analysis - Hedge Fund Holdings

Zimmer Biomet (ZBH) is a publicly traded Healthcare sector company. As of May 20, 2026, ZBH trades at $85.64 with a market cap of $16.47B and a P/E ratio of 24.44. ZBH moved -0.94% today. Year to date, ZBH is -7.85%; over the trailing twelve months it is -10.46%. Its 52-week range spans $79.12 to $114.72. Analyst consensus is neutral with an average price target of $97.08. Rallies surfaces ZBH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ZBH stock?

Hedge funds tracked by Rallies that own ZBH include Harris Associates, Pinebridge Investments, Bridgewater Associates, Panagora Asset, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Zimmer Biomet.

ZBH Key Metrics

Key financial metrics for ZBH
Metric	Value
Price	$85.64
Market Cap	$16.47B
P/E Ratio	24.44
EPS	$3.56
Dividend Yield	0.24%
52-Week High	$114.72
52-Week Low	$79.12
Volume	2.03M
Avg Volume	0
Revenue (TTM)	$8.23B
Net Income	$705.10M
Gross Margin	69.70%

Top Hedge Funds Holding ZBH

Harris Associates holds 12.96M shares of ZBH, changed +5.67% as of Mar 31, 2026.
Pinebridge Investments holds 77.30K shares of ZBH, changed -14.65% as of Dec 31, 2024.
Bridgewater Associates holds 33.99K shares of ZBH, changed +8.85% as of Mar 31, 2026.
Panagora Asset holds 9.72K shares of ZBH, changed -27.91% as of Sep 30, 2025.
Mangrove Partners holds 8.36K shares of ZBH, changed +0.00% as of Sep 30, 2024.

Latest ZBH News

Zimmer Biomet lifts 2026 buyback expectation to $1 billion, up $250 million — May 12, 2026
Zimmer Biomet jumps as investors revisit Q1 beat and raised 2026 EPS outlook — Apr 30, 2026
Zimmer Biomet slides after Q1 beat as CFO exit and margin scrutiny weigh — Apr 29, 2026
Zimmer Biomet Q1 Revenue Climbs 9.3% While EPS Jumps 15% — Apr 29, 2026
Zimmer Biomet slides after Q1 beat, CFO exit disclosed alongside outlook update — Apr 28, 2026

Recent ZBH Insider Trades

Winkler Lori sold 2.65K (~$250.85K) on Mar 12, 2026.
Yi Sang sold 1.00K (~$96.49K) on Feb 12, 2026.

ZBH Analyst Consensus

16 analysts cover ZBH: 0 strong buy, 4 buy, 11 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $97.08.

Common questions about ZBH

Who owns ZBH stock?: Hedge funds tracked by Rallies that own ZBH include Harris Associates, Pinebridge Investments, Bridgewater Associates, Panagora Asset, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Zimmer Biomet.
Does Rallies show 13F holders for ZBH?: Yes. Rallies tracks hedge fund and 13F ownership data for ZBH, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ZBH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ZBH. It does not provide personalized investment advice.